Reverse Vaccinology
Reverse vaccinology is a powerful approach to developing vaccines based on analysis of the entire genome of a pathogen.1,2 The video below will emphasize the highlights and advantages of this vaccine technology compared to classical vaccinology:
References
Seib KL, Zhao X, Rappuoli R. Developing vaccines in the era of genomics: a decade of reverse vaccinology. Clin Microbiol Infect 2012;18:109–116. Strugnell R, Zepp F, Cunningham AL et al. Vaccine antigens. Understanding modern vaccines. Perspect Vaccinol 2011;1:61–88. Rappuoli R. Reverse vaccinology, a genome-based approach to vaccine development. Vaccine 2001;19:2688–2691. Sette A, Rappuoli R. Reverse vaccinology: developing vaccines in the era of genomics. Immunity 2010;33:530–541.
Material supplied by the above-country business unit to LOCs for localisation must be subject to local Medical and/or Regulatory review and approval prior to use and/or external distribution.
LOCs to insert local adverse events reporting procedure.
© 2022 GSK group of companies or its licensor. GlaxoSmithKline Biologicals SA. Rixensart, Belgium.
NX-GBL-GVX-WCNT-220013 | October 2022